Bioworld Financial Watch articles from November 2007

Bioworld Financial Watch archives from November 2007

Anti-CD20 drugs: magic bullet in treating 'enigmatic' lupus?(Many Trials, Many Tribulations)
November 5, 2007... Genelabs Technologies Inc.'s $23.7 million financing at the start of October sparked renewed interest in its Phase III drug Prestara for lupus - and in the indication itself, for which a new therapy based on randomized, placebo-controlled...

Corrections and clarifications.(Correction notice)
November 5, 2007... A story in the Oct. 29, 2007, issue of BioWorld Financial Watch should have said Orencia is a selective co-stimulation modulator that inhibits T cell activation by binding to CD80 and CD86, thereby blocking interaction with CD28. Editor's...

Collaborations between Biotech and Pharmaceutical companies: Aug. 17 - Nov. 1, 2007.
November 5, 2007... Collaborations Between Biotech And Pharmaceutical Companies: Aug. 17 - Nov. 1, 2007# Biotech Co.* Pharma Co. Type/Product Area (Country; Symbol) (Country) Ablynx NV* Boehringer Agreement to...

Manufacturing, marketing and distribution agreements between Biotech and Pharmaceutical companies: Aug. 17 - Nov. 1, 2007.
November 5, 2007... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Aug. 17 - Nov. 1, 2007# Biotech Co.* Pharma Co. (Country) Type/Product Area (Country; Symbol) Access ...

Biotech--Big Pharma collaborations: modified and terminated agreements, Aug. 17 -Nov. 1, 2007.
November 5, 2007... Biotech--Big Pharma Collaborations: Modified And Terminated Agreements, Aug. 17 -Nov. 1, 2007# I. MODIFIED AGREEMENTS Biotech Co.* Pharma Co. Change from original (Country; (Country) agreement...

BioWorld stock report for public Biotechnology Companies.
November 5, 2007... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 10/26 11/02 WK YTD (000) Aastrom Biosci ASTM 1.05 1.02...

Momenta's trials may continue as FDA slows generic Lovenox.(Same Questions Dog Others In Race)
November 12, 2007... The FDA's stance on generics -- at least on versions of the blood thinner Lovenox, such as Momenta Pharmaceuticals Inc.'s M-Enoxaparin (and probably similar compounds from Teva Pharmaceuticals Industries Ltd. and Amphastar Pharmaceuticals Inc....

Clarification.(Correction notice)
November 12, 2007... An article in the Nov. 5, 2007 issue of BioWorld Financial Watch should have noted that Rituxan is the result of a partnership between Genentech and Biogen Idec, and that ocrelizumab is the subject of a collaboration between Genentech, F....

Public financing of biotechnology: October 2007.
November 12, 2007... I. COMMENCED TRADING IN OCTOBER Company Date Date Shares/ Price Shares (Symbol) # Filed Comm. Units (M) Out (M) @...

Audio conference focuses on personalized medicine.(Conference news)
November 12, 2007... Reality will soon come to medical practices specifically geared to individuals based on their genetic makeup. A new report issued by the HHS pinpoints work that lies ahead for the government, biotechnology and pharmaceutical companies, and...

Other Financings of Public Biotechnology Companies: October 2007.
November 12, 2007... Other Financings Of Public Biotechnology Companies: October 2007 TOTAL: $709.15M Company (Symbol) # Type Of Financing Number Of Shares, Units ...

Venture Capital and other investments in Private Biotechnology Companies: October 2007.
November 12, 2007... FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $462.55M Company Location Date Amt. Details (M) Abiant Inc. Chicago 10/1 $0.6 Abiant raised ...

Milestone payments and equity investment from corporate partners: October 2007.
November 12, 2007... TOTAL: $25M Year to Date: $938.65M Company #* Partner Amt. Triggering (Symbol) (Country) (M) Event Coley GlaxoSmithKline $3 Milestone Pharmaceuticals plc (UK) ...

Audio conference helps companies avoid device recall.(Conference news)
November 12, 2007... Med-tech companies must have systems in place that receive, investigate, analyze, and act on complaints from users, patients, and professionals. FDA's Center for Devices and Radiological Health (CDRH) has recently put into place certain action...

The BioWorld BioPartnering report 2008: market bellwethers and success dynamics.
November 12, 2007... Biopartnering is the life sciences business phenomenon of the twenty-first century and the BioWorld BioPartnering Report is the complete guide to facilitate your beginning-to-end opportunity and participation in the partnering process. ...

Money raised by Biotech in 2007: January-October.
November 12, 2007... Money Raised By Biotech In 2007: January-October Type of Jan. Feb. March April May June financing Public 573.5 655.4 1 74.1 559.1 1,257.5 568.7 offerings Private 518.7 ...

BioWorld Stock Indicator 2007, Nasdaq Biotech Index 2007.
November 12, 2007... These graphs compare the performance of the biotech stocks for all of 2007 using two different measures. The BioWorld Stock Indicator measures the average percent change year to date in the 307 U.S. biotech and biotech-related stocks that...

BioWorld stock report for Public Biotechnology companies.
November 12, 2007... BioWorld Stock Report for Public Biotechnology Companies Company Symbol Close Close %Change Vol 11/2 11/9 WK YTD (000) Aastrom Biosci ASTM 1.02 ...

Can champ Aloxi be toppled in CINV market? Answer soon.('Highly Emetogenic, Delayed Onset' Key)
November 19, 2007... Among drugs for the consequences of chemo, those with the highest profile are Amgen Inc.'s erythropoietin stimulating agents, Epogen (epoetin alfa) and Aranesp (darbepoetin alfa), and Ortho Biotech Products LP's Procrit (epoetin alfa) - all...

Clinical trials update: October 2007.
November 19, 2007... Clinical Trials Update: October 2007 Company * (Country; Product Description Symbol) AUTOIMMUNE Alpharma ALO-01 An extended-release Inc. (NYSE:ALO) ...

Non-U.S. clinical trials and regulatory actions: October 2007.
November 19, 2007... Non-U.S. Clinical Trials And Regulatory Actions: October 2007 Company * (Country; Product Description Symbol) AUTOIMMUNE Argenes Inc.* ARG098 An anti-Fas IgM ...

FDA submissions, approvals and other actions: October 2007.
November 19, 2007... FDA Submissions, Approvals And Other Actions: October 2007 Company * Product Description (Country; Symbol) CANCER BioDelivery BEMA Fentanyl A dissolvable Sciences polymer...

BioWorld stock report for public biotechnology companies.
November 19, 2007... Bioworld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 11/9 11/16 WK YTD (000) Aastrom Biosci ASTM 0.9 ...

Targanta revives oritavancin: next weapon against cSSSI?(Analysts: 'High Risk, High Reward')(complicated skin and skin structure infection)
November 26, 2007... Remember FDA-stalled oritavancin? The hospital-based glycopeptide antibiotic acquired in 2001 by InterMune Inc. from Eli Lilly and Co. (which developed the compound as a replacement for vancomycin, which still takes an estimated 80 percent...

Money raised by biotech in 2007 vs. 2006.(biotechnology companies)(Table)(Brief article)
November 26, 2007... Money Raised By Biotech In 2007 Vs. 2006 Jan. 1--Nov. 20, 2007: Jan. 1--Nov. 21, 2006: $22,892.75M $17,108.79M Public/Other * 12,186 7,013 Private...

10 biggest U.S. gainers for the week.(biotechnology industry)(Table)(Brief article)
November 26, 2007... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Ziopharm 47.09 Pharmion 15.86 Pharmion 32.18 Ziopharm 1.05 Catalyst Pharma 18.00 Myriad Genetics ...

10 biggest U.S. losers for the week.(biotechnology companies)(Table)(Brief article)
November 26, 2007... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Memory Pharma -29.07 IDEXX Laboratories -7.63 Biomira -28.30 Alexion Pharma -5.05 VaxGen -23.08 Omrix Biopharma ...

Biotech collabratilons and other actions in agriculture and animals: Nov. 21, 2006--Nov. 20, 2007.(biotechnology companies)(Table)
November 26, 2007... Biotech Collaborations And Other Actions In Agriculture And Animals: Nov. 21, 2006 - Nov. 20, 2007 Biotech Co. * Agbiotech Type/Product Area (Country; Partner/Institution Symbol) Accera Inc. * Nestle Purina...

Bioworld stock report for public biotechnology companies.(Table)
November 26, 2007... Company Symbol Close Close %Change Vol 11/16 11/21 WK YTD (000) Aastrom Biosci ASTM 0.86 0.91 5.81 -26.02 3117 Acadia Pharma ACAD ...